RecruitingPhase 3NCT06307652
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Sponsor: AstraZeneca
Bridgewater, NJ · Jersey City, NJ · Somerset, NJ · +163 more sites
Clinical trials in Jersey City, NJ
9 recruiting studies have a site in or near Jersey City, NJ, New Jersey.
Top conditions here
- Breast Cancer (4)
- Colorectal Cancer (2)
- Heart Failure (2)
- Type 2 Diabetes (2)
- Obesity (1)
- Type 1 Diabetes (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 9 of 9 studies
RecruitingPhase 3NCT07743450
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Sponsor: Ascletis Pharma (China) Co., Limited
Jersey City, NJ · +83 more sites
RecruitingPhase 3NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor: NRG Oncology
Camden, NJ · Cherry Hill, NJ · Elizabeth, NJ · +1223 more sites
RecruitingPhase 3NCT07784725
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Jersey City, NJ · +32 more sites
RecruitingPhase 3NCT07567001
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Sponsor: Novo Nordisk A/S
Elmer, NJ · Hackettstown, NJ · Haddon Heights, NJ · +203 more sites
RecruitingPhase 3NCT05812807
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Sponsor: Alliance for Clinical Trials in Oncology
Camden, NJ · Cherry Hill, NJ · Elizabeth, NJ · +825 more sites
RecruitingPhase 2NCT05806931
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
Sponsor: Rutgers, The State University of New Jersey
Elizabeth, NJ · Jersey City, NJ · Lakewood, NJ · +6 more sites
RecruitingPhase 2NCT05559164
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Sponsor: Rutgers, The State University of New Jersey
Elizabeth, NJ · Hamilton, NJ · Jersey City, NJ · +7 more sites
RecruitingPhase 4NCT07158164
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Sponsor: Rutgers, The State University of New Jersey
Belleville, NJ · Elizabeth, NJ · Hamilton, NJ · +9 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.